A novel method providing a more accurate LDL-C assessment leading to a more robust basis for personalized clinical decision-making
Clinical Testing for Titin and Ryanodine Receptor Autoantibodies in Myasthenia Gravis Patients
   A new study supports assessment of family history and genetic predisposition in addition to established cardiometabolic risk factors.
Geographic Disparities in Access to Syringe Services Programs Among Young People with Hepatitis C Virus Infection in the US
Myasthenia Gravis
Improving the Positive Predictive Value of Noninvasive Prenatal Screening (NIPS)

Browse by Medical Specialty


Comprehensive Screening for Clearer Insight: QNatal® Advanced

This educational webinar is presented in Spanish. Quest Diagnostics Arturo Anguiano, MD, delivers this educational webinar for the benefit of those in Spanish speaking markets.... Read more 


Assessment of LDL-C in the Modern Era: Using a More Accurate LDL-C Estimate to Inform Personalized Clinical Decision-Making

Dr Martin explains the limitations of Friedewald-estimated LDL cholesterol; identifies patients in whom it is less accurate and how to recognize a more accurate, validated... Read more 


The Importance of Infectious-Disease Testing in Injection Drug Users

Dr. Opesanmi discusses testing recommendations beyond drug monitoring for the injection drug user. Read more 

Search Webinars

OncoKB: A Precision Oncology Knowledge Base

Quest Diagnostics Authors: Hantash, F

J Clin Oncol. 2017;1:1−16.

Specialties: Oncology

Read the Key Summary (Download PDF)